Publication Details

Need to talk? Call us free*
0800 808 00 00 7 days a week, 8am-8pm
Palbociclib (Ibrance ®) (Polish)

Palbociclib (Ibrance ®) (Polish) (June 2018)

Palbociclib (Ibrance®) is a targeted therapy drug used to treat breast cancer that is oestrogen receptor positive and HER 2 negative. This factsheet describes what it is, how it is given, and possible side effects. 

Author(s)
Macmillan Cancer Support
Place of publication
London
Date of publication
June 2018
Pages
7pp
Format
Factsheet
Language
Polish
Download this resource
Need to talk? Call us free*
0800 808 00 00 7 days a week, 8am-8pm